Keywords
Last Name
Institution

Leonard Gomella

TitleProfessor & Chair JMC
InstitutionThomas Jefferson University
DepartmentChair SKMC
Address1025 Walnut St.
Philadelphia PA 19107
Phone215-955-1702
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Gomella LG. Prostate Cancer CRPC Stage M0 and M1: Do We Need Stage M0.5? Can J Urol. 2018 Apr; 25(2):9220. PMID: 29679997.
      View in: PubMed
    2. Jacene H, Gomella L, Yu EY, Rohren EM. Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical Considerations. Clin Genitourin Cancer. 2018 Mar 23. PMID: 29678471.
      View in: PubMed
    3. Mark JR, Kelly WK, Gomella LG. Multidisciplinary Clinical Treatment of Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2018 Mar 15. PMID: 29543958.
      View in: PubMed
    4. Truong H, Gomella LG, Thakur ML, Trabulsi EJ. VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen. World J Urol. 2018 Mar 14. PMID: 29541892.
      View in: PubMed
    5. Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018 Feb 01; 36(4):414-424. PMID: 29236593.
      View in: PubMed
    6. Gomella LG. New Urologic Oncology Drugs and The New Toxicities. Can J Urol. 2017 Dec; 24(6):9075. PMID: 29260629.
      View in: PubMed
    7. Gomella LG. Where have all the sperm gone? Can J Urol. 2017 10; 24(5):8972. PMID: 28971781.
      View in: PubMed
    8. Shore ND, Boorjian SA, Canter DJ, Ogan K, Karsh LI, Downs TM, Gomella LG, Kamat AM, Lotan Y, Svatek RS, Bivalacqua TJ, Grubb RL, Krupski TL, Lerner SP, Woods ME, Inman BA, Milowsky MI, Boyd A, Treasure FP, Gregory G, Sawutz DG, Yla-Herttuala S, Parker NR, Dinney CPN. Intravesical rAd-IFNa/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study. J Clin Oncol. 2017 Oct 20; 35(30):3410-3416. PMID: 28834453.
      View in: PubMed
    9. Mark JR, Gomella LG. Nonpalpable Intratesticular Mass in a Young Man With a History of Contralateral Retractile Testis. Oncology (Williston Park). 2017 06 15; 31(6):484, 489-91. PMID: 28620904.
      View in: PubMed
    10. Gomella LG. The Urology Guide to Coffee and Tea. Can J Urol. 2017 Jun; 24(3):8782-8783. PMID: 28646930.
      View in: PubMed
    11. Tripathi SK, Kumar P, Trabulsi EJ, Kim S, McCue PA, Intenzo C, Berger A, Gomella L, Thakur ML. VPAC1 Targeted 64Cu-TP3805 kit preparation and its evaluation. Nucl Med Biol. 2017 Aug; 51:55-61. PMID: 28577428.
      View in: PubMed
    12. Tanimoto R, Palladino C, Xu SQ, Buraschi S, Neill T, Gomella LG, Peiper SC, Belfiore A, Iozzo RV, Morrione A. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin. Matrix Biol. 2017 Dec; 64:27-39. PMID: 28433812.
      View in: PubMed
    13. Gomella LG. The Liquid Biopsy for Prostate Cancer 25 Years Later. Can J Urol. 2017 Apr; 24(2):8693-8694. PMID: 28436352.
      View in: PubMed
    14. Crawford ED, Petrylak DP, Shore N, Saad F, Slovin SF, Vogelzang NJ, Keane TE, Koo PJ, Gomella LG, O'Sullivan JM, Tombal B, Concepcion RS, Sieber P, Stone NN, Finkelstein SE, Yu EY. The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II). Urology. 2017 Jun; 104:150-159. PMID: 28302580.
      View in: PubMed
    15. Trabulsi EJ, Tripathi SK, Gomella L, Solomides C, Wickstrom E, Thakur ML. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study. BJU Int. 2017 Jun; 119(6):885-895. PMID: 28075510.
      View in: PubMed
    16. Gomella LG, Mann MJ, Cleary RC, Hubosky SG, Bagley DH, Thumar AB, McCue PA, Lallas CD, Trabulsi EJ. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date. Can J Urol. 2017 Feb; 24(1):8620-8626. PMID: 28263126.
      View in: PubMed
    17. Gomella LG. Prostate Cancer Statistics: Anything You Want Them To Be. Can J Urol. 2017 Feb; 24(1):8603-8604. PMID: 28263123.
      View in: PubMed
    18. Truong H, Hegarty SE, Gomella LG, Kelly WK, Trabulsi EJ, Lallas CD, Giri VN. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts. J Genet Couns. 2017 Jun; 26(3):548-555. PMID: 28101821.
      View in: PubMed
    19. Gomella LG. Editorial Comment. J Urol. 2017 Mar; 197(3 Pt 1):601. PMID: 27992742.
      View in: PubMed
    20. Gomella LG. Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots. Can J Urol. 2016 Oct; 23(5):8429. PMID: 27705725.
      View in: PubMed
    21. Kim H, Alshalalfa M, Hoffman-Censits J, Lallas CD, Davicioni E, Lin J, Birbe R, Erho N, Lehrer J, Ashab HA, Takhar M, Olson A, Lam LL, Kelly WK, Knudsen KE, Thangavel C, Seiler R, Feng FY, Schaeffer EM, Trabulsi EJ, Gomella LG, Hurwitz MD, Dicker AP, Den RB. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report. Urol Case Rep. 2016 Nov; 9:51-54. PMID: 27713863.
      View in: PubMed
    22. Ju X, Jiao X, Ertel A, Casimiro MC, Di Sante G, Deng S, Li Z, Di Rocco A, Zhan T, Hawkins A, Stoyanova T, Andò S, Fatatis A, Lisanti MP, Gomella LG, Languino LR, Pestell RG. v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1. Cancer Res. 2016 Nov 15; 76(22):6723-6734. PMID: 27634768.
      View in: PubMed
    23. Gomella LG. Big Data Equals Big Challenges for Prostate Cancer. Can J Urol. 2016 Aug; 23(4):8329. PMID: 27544553.
      View in: PubMed
    24. Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM, Carroll P, Eastham J, Gomella L, Klein EA. An Approach Using PSA Levels of 1.5?ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care. Urology. 2016 Oct; 96:116-120. PMID: 27450937.
      View in: PubMed
    25. Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study. J Cancer Educ. 2016 Jul 15. PMID: 27418065.
      View in: PubMed
    26. Buraschi S, Xu SQ, Stefanello M, Moskalev I, Morcavallo A, Genua M, Tanimoto R, Birbe R, Peiper SC, Gomella LG, Belfiore A, Black PC, Iozzo RV, Morrione A. Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin. Oncotarget. 2016 Jun 28; 7(26):39980-39995. PMID: 27220888.
      View in: PubMed
    27. Dan TD, Doyle L, Raval AJ, Pridjian A, Gomella LG, Den RB. Dosing, administration, and safety of radium-223: How I do it. Can J Urol. 2016 Jun; 23(3):8301-5. PMID: 27347625.
      View in: PubMed
    28. Gomella LG. TV Drug Commercials: Keeping Physicians Informed. Can J Urol. 2016 Apr; 23(2):8188. PMID: 27085820.
      View in: PubMed
    29. Giri VN, Gross L, Gomella LG, Hyatt C. How I Do It: Genetic counseling and genetic testing for inherited prostate cancer. Can J Urol. 2016 Apr; 23(2):8247-53. PMID: 27085833.
      View in: PubMed
    30. Fizazi K, Chi KN, de Bono JS, Gomella LG, Miller K, Rathkopf DE, Ryan CJ, Scher HI, Shore ND, De Porre P, Londhe A, McGowan T, Pelhivanov N, Charnas R, Todd MB, Montgomery B. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. 2016 Sep; 70(3):438-44. PMID: 26965562.
      View in: PubMed
    31. Gomella LG. Punishing Physicians for PSA Screening. Can J Urol. 2015 Dec; 22(6):8042. PMID: 26688130.
      View in: PubMed
    32. Tripathi S, Trabulsi EJ, Gomella L, Kim S, McCue P, Intenzo C, Birbe R, Gandhe A, Kumar P, Thakur M. VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man. Urology. 2016 Feb; 88:111-8. PMID: 26519886.
      View in: PubMed
    33. Gomella LG. Robotic and Open Radical Prostatectomy: Celebrating Oncologic Equivalence. Can J Urol. 2015 Oct; 22(5):7942-3. PMID: 26432961.
      View in: PubMed
    34. Talati PG, Gu L, Ellsworth EM, Girondo MA, Trerotola M, Hoang DT, Leiby B, Dagvadorj A, McCue PA, Lallas CD, Trabulsi EJ, Gomella L, Aplin AE, Languino L, Fatatis A, Rui H, Nevalainen MT. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer. Am J Pathol. 2015 Sep; 185(9):2505-22. PMID: 26362718.
      View in: PubMed
    35. Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H. A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902. Int J Radiat Oncol Biol Phys. 2015 Oct 1; 93(2):294-302. PMID: 26209502.
      View in: PubMed
    36. Goodwin JF, Kothari V, Drake JM, Zhao S, Dylgjeri E, Dean JL, Schiewer MJ, McNair C, Jones JK, Aytes A, Magee MS, Snook AE, Zhu Z, Den RB, Birbe RC, Gomella LG, Graham NA, Vashisht AA, Wohlschlegel JA, Graeber TG, Karnes RJ, Takhar M, Davicioni E, Tomlins SA, Abate-Shen C, Sharifi N, Witte ON, Feng FY, Knudsen KE. DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis. Cancer Cell. 2015 Jul 13; 28(1):97-113. PMID: 26175416.
      View in: PubMed
    37. Chu FM, Sartor O, Gomella L, Rudo T, Somerville MC, Hereghty B, Manyak MJ. A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer. Eur J Cancer. 2015 Aug; 51(12):1555-69. PMID: 26048455.
      View in: PubMed
    38. Liao Z, Gu L, Vergalli J, Mariani SA, De Dominici M, Lokareddy RK, Dagvadorj A, Purushottamachar P, McCue PA, Trabulsi E, Lallas CD, Gupta S, Ellsworth E, Blackmon S, Ertel A, Fortina P, Leiby B, Xia G, Rui H, Hoang DT, Gomella LG, Cingolani G, Njar V, Pattabiraman N, Calabretta B, Nevalainen MT. Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia. Mol Cancer Ther. 2015 Aug; 14(8):1777-93. PMID: 26026053.
      View in: PubMed
    39. Xu SQ, Buraschi S, Morcavallo A, Genua M, Shirao T, Peiper SC, Gomella LG, Birbe R, Belfiore A, Iozzo RV, Morrione A. A novel role for drebrin in regulating progranulin bioactivity in bladder cancer. Oncotarget. 2015 May 10; 6(13):10825-39. PMID: 25839164.
      View in: PubMed
    40. George DJ, Nabhan C, DeVries T, Whitmore JB, Gomella LG. Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy. Cancer Immunol Res. 2015 Sep; 3(9):1063-9. PMID: 25943532.
      View in: PubMed
    41. Tanimoto R, Fashola Y, Scotland KB, Calvaresi AE, Gomella LG, Trabulsi EJ, Lallas CD. Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience. BMC Urol. 2015; 15(1):27. PMID: 25879548.
      View in: PubMed
    42. Gomella LG. The testosterone storm. Can J Urol. 2015 Apr; 22(2):7677. PMID: 25891328.
      View in: PubMed
    43. Dan TD, Eldredge-Hindy HB, Hoffman-Censits J, Lin J, Kelly WK, Gomella LG, Lallas CD, Trabulsi EJ, Hurwitz MD, Dicker AP, Den RB. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies. Am J Clin Oncol. 2015 Feb 25. PMID: 25723740.
      View in: PubMed
    44. Londin E, Loher P, Telonis AG, Quann K, Clark P, Jing Y, Hatzimichael E, Kirino Y, Honda S, Lally M, Ramratnam B, Comstock CE, Knudsen KE, Gomella L, Spaeth GL, Hark L, Katz LJ, Witkiewicz A, Rostami A, Jimenez SA, Hollingsworth MA, Yeh JJ, Shaw CA, McKenzie SE, Bray P, Nelson PT, Zupo S, Van Roosbroeck K, Keating MJ, Calin GA, Yeo C, Jimbo M, Cozzitorto J, Brody JR, Delgrosso K, Mattick JS, Fortina P, Rigoutsos I. Analysis of 13 cell types reveals evidence for the expression of numerous novel primate- and tissue-specific microRNAs. Proc Natl Acad Sci U S A. 2015 Mar 10; 112(10):E1106-15. PMID: 25713380.
      View in: PubMed
    45. de Leeuw R, Berman-Booty LD, Schiewer MJ, Ciment SJ, Den RB, Dicker AP, Kelly WK, Trabulsi EJ, Lallas CD, Gomella LG, Knudsen KE. Novel actions of next-generation taxanes benefit advanced stages of prostate cancer. Clin Cancer Res. 2015 Feb 15; 21(4):795-807. PMID: 25691773.
      View in: PubMed
    46. Den RB, Yousefi K, Trabulsi EJ, Abdollah F, Choeurng V, Feng FY, Dicker AP, Lallas CD, Gomella LG, Davicioni E, Karnes RJ. Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy. J Clin Oncol. 2015 Mar 10; 33(8):944-51. PMID: 25667284.
      View in: PubMed
    47. Gomella LG. What's wrong with the practice of medicine today? Can J Urol. 2015 Feb; 22(1):7589. PMID: 25694003.
      View in: PubMed
    48. Mishra MV, Scher ED, Andrel J, Margules AC, Hegarty SE, Trabulsi EJ, Hyslop T, Den RB, Lallas CD, Gomella LG, Dicker AP, Showalter TN. Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Patients With Adverse Pathologic Features: Comparative Analysis of Long-term Outcomes. Am J Clin Oncol. 2015 Feb; 38(1):55-60. PMID: 24051934.
      View in: PubMed
    49. Shore ND, Karsh L, Gomella LG, Keane TE, Concepcion RS, Crawford ED. Avoiding obsolescence in advanced prostate cancer management: a guide for urologists. BJU Int. 2015 Feb; 115(2):188-97. PMID: 25756134.
      View in: PubMed
    50. Tanimoto R, Morcavallo A, Terracciano M, Xu SQ, Stefanello M, Buraschi S, Lu KG, Bagley DH, Gomella LG, Scotlandi K, Belfiore A, Iozzo RV, Morrione A. Sortilin regulates progranulin action in castration-resistant prostate cancer cells. Endocrinology. 2015 Jan; 1(1):58-70. PMID: 25365768.
      View in: PubMed
    51. Pisansky TM, Hunt D, Gomella LG, Amin MB, Balogh AG, Chinn DM, Seider MJ, Duclos M, Rosenthal SA, Bauman GS, Gore EM, Rotman MZ, Lukka HR, Shipley WU, Dignam JJ, Sandler HM. Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910. J Clin Oncol. 2015 Feb 1; 33(4):332-9. PMID: 25534388.
      View in: PubMed
    52. Gomella LG. When 4 does not mean 4: A patient portal lesson. Can J Urol. 2014 Dec; 21(6):7516. PMID: 25483755.
      View in: PubMed
    53. Calvaresi AE, Trabulsi EJ, Sonzogni M, Gomella LG, Lallas CD, Wachsmuth KS. Implementing Hexaminolevulinate HCl Blue Light Cystoscopy: A Nursing Perspective. AORN J. 2014 Nov; 100(5):489-99. PMID: 25443119.
      View in: PubMed
    54. Lallas CD, Fashola Y, Den RB, Gelpi-Hammerschmidt F, Calvaresi AE, McCue P, Birbe R, Gomella LG, Trabulsi EJ. Predictors of positive surgical margins after radical prostatectomy at a single institution: preoperative and pathologic factors, and the impact of surgeon variability and technique on incidence and location. Can J Urol. 2014 Oct; 21(5):7479-86. PMID: 25347375.
      View in: PubMed
    55. Daneshmand S, Schuckman AK, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96. PMID: 25245244.
      View in: PubMed
    56. Lin J, Zhan T, Duffy D, Hoffman-Censits J, Kilpatrick D, Trabulsi EJ, Lallas CD, Chervoneva I, Limentani K, Kennedy B, Kessler S, Gomella L, Antonarakis ES, Carducci MA, Force T, Kelly WK. A pilot phase II Study of digoxin in patients with recurrent prostate cancer as evident by a rising PSA. Am J Cancer Ther Pharmacol. 2014 Sep 7; 2(1):21-32. PMID: 25580468.
      View in: PubMed
    57. Den RB, Feng FY, Showalter TN, Mishra MV, Trabulsi EJ, Lallas CD, Gomella LG, Kelly WK, Birbe RC, McCue PA, Ghadessi M, Yousefi K, Davicioni E, Knudsen KE, Dicker AP. Genomic prostate cancer classifier predicts biochemical failure and metastases in patients after postoperative radiation therapy. Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89(5):1038-46. PMID: 25035207.
      View in: PubMed
    58. Andriole GL, Bostwick DG, Gomella LG, Marberger M, Montorsi F, Tammela TL, Tindall DJ, Fowler IL, Garges HP, Wilson TH, Castro R. Modeling and Analysis of Gleason Score 8-10 Prostate Cancers in the REDUCE Study. Urology. 2014 Aug; 84(2):393-9. PMID: 24916669.
      View in: PubMed
    59. Gomella LG. Prostate cancer and prostatocystitis: Equal in the eyes of ICD-10. Can J Urol. 2014 Jun; 21(4):7330-1. PMID: 25171273.
      View in: PubMed
    60. Gomella LG. Clinical Trials: Naming Confusion or YABA? Can J Urol. 2014 Jun; 21(3):7255. PMID: 24978352.
      View in: PubMed
    61. Gomella LG. Recommendations for adjuvant post prostatectomy radiation. Can J Urol. 2014 Jun; 21(3):7298. PMID: 24978360.
      View in: PubMed
    62. Gomella LG. Prostate cancer: Alcohol, cancer and 5a-reductase inhibitors-is there a link? Nat Rev Urol. 2014 May; 11(5):253-4. PMID: 24776974.
      View in: PubMed
    63. Witjes JA, Gomella LG, Stenzl A, Chang SS, Zaak D, Grossman HB. Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data. Urology. 2014 Jul; 84(1):122-6. PMID: 24768013.
      View in: PubMed
    64. Gomella LG, Petrylak DP, Shayegan B. Current management of advanced and castration resistant prostate cancer. Can J Urol. 2014 Apr; 21(2 Supp 1):1-6. PMID: 24775717.
      View in: PubMed
    65. Gomella LG, Gelpi-Hammerschmidt F, Kundavram C. Practical guide to immunotherapy in castration resistant prostate cancer: the use of sipuleucel-T immunotherapy. Can J Urol. 2014 Apr; 21(2 Supp 1):48-56. PMID: 24775724.
      View in: PubMed
    66. Gomella LG. Prostate cancer genomics: understanding the new landscape. Can J Urol. 2014 Feb; 21(1):7091. PMID: 24529006.
      View in: PubMed
    67. Crawford ED, Stone NN, Yu EY, Koo PJ, Freedland SJ, Slovin SF, Gomella LG, Berger ER, Keane TE, Sieber P, Shore ND, Petrylak DP. Challenges and recommendations for early identification of metastatic disease in prostate cancer. Urology. 2014 Mar; 83(3):664-9. PMID: 24411213.
      View in: PubMed
    68. Mishra MV, Shen X, Den RB, Champ CE, Trabulsi EJ, Lallas CD, Gomella LG, Dicker AP, Showalter TN. Patterns of Care for Elderly Men Diagnosed With Favorable-risk Prostate Cancer From 2004 to 2008: A Population-based Analysis. Am J Clin Oncol. 2013 Dec; 36(6):606-11. PMID: 22892435.
      View in: PubMed
    69. Gomella LG. Prostate cancer: a high value target for cost containment. Can J Urol. 2013 Oct; 20(5):6888. PMID: 24128823.
      View in: PubMed
    70. Morgan MA, Roberts NR, Pino LA, Trabulsi EJ, Brown DB, Gomella LG, Lallas CD. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery. Can J Urol. 2013 Oct; 20(5):6933-7. PMID: 24128832.
      View in: PubMed
    71. Ismail MT, Gomella LG. Transrectal prostate biopsy. Urol Clin North Am. 2013 Nov; 40(4):457-72. PMID: 24182969.
      View in: PubMed
    72. Mishra MV, Bennett M, Vincent A, Lee OT, Lallas CD, Trabulsi EJ, Gomella LG, Dicker AP, Showalter TN. Identifying barriers to patient acceptance of active surveillance: content analysis of online patient communications. PLoS One. 2013; 8(9):e68563. PMID: 24039699.
      View in: PubMed
    73. Zaorsky NG, Harrison AS, Trabulsi EJ, Gomella LG, Showalter TN, Hurwitz MD, Dicker AP, Den RB. Evolution of advanced technologies in prostate cancer radiotherapy. Nat Rev Urol. 2013 Oct; 10(10):565-79. PMID: 24018567.
      View in: PubMed
    74. Gu L, Liao Z, Hoang DT, Dagvadorj A, Gupta S, Blackmon S, Ellsworth E, Talati P, Leiby B, Zinda M, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Huszar D, Nevalainen MT. Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer. Clin Cancer Res. 2013 Oct 15; 19(20):5658-74. PMID: 23942095.
      View in: PubMed
    75. Gomella LG. Preventing and managing PSA recurrence following radical prostatectomy. Can J Urol. 2013 Jun; 20(3):6755. PMID: 23783042.
      View in: PubMed
    76. Dicker AP, Gomella LG, Kevin Kelly W. Introduction: the changing landscape of prostate cancer. Semin Oncol. 2013 Jun; 40(3):241-3. PMID: 23806490.
      View in: PubMed
    77. Healy KA, Gomella LG. Retropubic, laparoscopic, or robotic radical prostatectomy: is there any real difference? Semin Oncol. 2013 Jun; 40(3):286-96. PMID: 23806494.
      View in: PubMed
    78. Haddad BR, Gu L, Mirtti T, Dagvadorj A, Vogiatzi P, Hoang DT, Bajaj R, Leiby B, Ellsworth E, Blackmon S, Ruiz C, Curtis M, Fortina P, Ertel A, Liu C, Rui H, Visakorpi T, Bubendorf L, Lallas CD, Trabulsi EJ, McCue P, Gomella L, Nevalainen MT. STAT5A/B Gene Locus Undergoes Amplification during Human Prostate Cancer Progression. Am J Pathol. 2013 Jun; 182(6):2264-75. PMID: 23660011.
      View in: PubMed
    79. Gomella LG. Actos, slings, finasteride, and the vaccine compensation solution. Can J Urol. 2013 Apr; 20(2):6668. PMID: 23587504.
      View in: PubMed
    80. Bjurlin MA, Carter HB, Schellhammer P, Cookson MS, Gomella LG, Troyer D, Wheeler TM, Schlossberg S, Penson DF, Taneja SS. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol. 2013 Jun; 189(6):2039-46. PMID: 23485507.
      View in: PubMed
    81. Gomella LG, Oliver Sartor A. The current role and limitations of surrogate endpoints in advanced prostate cancer. Urol Oncol. 2014 Jan; 32(1):28.e1-9. PMID: 23433893.
      View in: PubMed
    82. Gomella LG. CAUTI and Readmission Penalties: Urologists Beware. Can J Urol. 2013 Feb; 20(1):6592. PMID: 23433126.
      View in: PubMed
    83. Zaorsky NG, Studenski MT, Dicker AP, Gomella L, Den RB. Stereotactic body radiation therapy for prostate cancer: Is the technology ready to be the standard of care? Cancer Treat Rev. 2013 May; 39(3):212-8. PMID: 23218442.
      View in: PubMed
    84. Gomella LG. Circumcision: a spiritual, medical or criminal act? Can J Urol. 2012 Dec; 19(6):6530. PMID: 23228286.
      View in: PubMed
    85. Schiewer MJ, Goodwin JF, Han S, Brenner JC, Augello MA, Dean JL, Liu F, Planck JL, Ravindranathan P, Chinnaiyan AM, McCue P, Gomella LG, Raj GV, Dicker AP, Brody JR, Pascal JM, Centenera MM, Butler LM, Tilley WD, Feng FY, Knudsen KE. Dual roles of PARP-1 promote cancer growth and progression. Cancer Discov. 2012 Dec; 2(12):1134-49. PMID: 22993403.
      View in: PubMed
    86. Halpern EJ, Gomella LG, Forsberg F, McCue PA, Trabulsi EJ. Contrast enhanced transrectal ultrasound for the detection of prostate cancer: a randomized, double-blind trial of dutasteride pretreatment. J Urol. 2012 Nov; 188(5):1739-45. PMID: 22998915.
      View in: PubMed
    87. Gomella LG. Heath care reform: the carrot, the stick and the hippocratic oath. Can J Urol. 2012 Aug; 19(4):6324. PMID: 22892252.
      View in: PubMed
    88. Champ CE, Hegarty SE, Shen X, Mishra MV, Dicker AP, Trabulsi EJ, Lallas CD, Gomella LG, Hyslop T, Showalter TN. Prognostic factors and outcomes after definitive treatment of female urethral cancer: a population-based analysis. Urology. 2012 Aug; 80(2):374-81. PMID: 22857759.
      View in: PubMed
    89. Rove KO, Debruyne FM, Djavan B, Gomella LG, Koul HK, Lucia MS, Petrylak DP, Shore ND, Stone NN, Crawford ED. Role of testosterone in managing advanced prostate cancer. Urology. 2012 Oct; 80(4):754-62. PMID: 22795376.
      View in: PubMed
    90. Genua M, Xu SQ, Buraschi S, Peiper SC, Gomella LG, Belfiore A, Iozzo RV, Morrione A. Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells. PLoS One. 2012; 7(6):e40148. PMID: 22859931.
      View in: PubMed
    91. Gomella LG. Can anyone spare a little indigo carmine? The drug shortage crisis. Can J Urol. 2012 Jun; 19(3):6238. PMID: 22704304.
      View in: PubMed
    92. Gomella LG. Prostate cancer: The benefits of multidisciplinary prostate cancer care. Nat Rev Urol. 2012 Jul; 9(7):360-2. PMID: 22565373.
      View in: PubMed
    93. Kelly DC, Margules AC, Kundavaram CR, Narins H, Gomella LG, Trabulsi EJ, Lallas CD. Face, content, and construct validation of the Da Vinci Skills Simulator. Urology. 2012 May; 79(5):1068-72. PMID: 22546387.
      View in: PubMed
    94. Gomella LG. The quest for the perfect prostate biopsy continues. J Urol. 2012 Jun; 187(6):1954-5. PMID: 22503025.
      View in: PubMed
    95. Kleinmann N, Zaorsky NG, Showalter TN, Gomella LG, Lallas CD, Trabulsi EJ. The effect of ethnicity and sexual preference on prostate-cancer-related quality of life. Nat Rev Urol. 2012 May; 9(5):258-65. PMID: 22487871.
      View in: PubMed
    96. Mark JR, Gelpi-Hammerschmidt F, Trabulsi EJ, Gomella LG. Blue light cystoscopy for detection and treatment of non-muscle invasive bladder cancer. Can J Urol. 2012 Apr; 19(2):6227-31. PMID: 22512972.
      View in: PubMed
    97. Gomella LG. Editorial: Renaming low risk prostate cancer: proceed cautiously. Can J Urol. 2012 Feb; 19(1):6069. PMID: 22316505.
      View in: PubMed
    98. Kelly WK, Gomella LG. Androgen deprivation therapy and competing risks. JAMA. 2011 Dec 7; 306(21):2382-3. PMID: 22147384.
      View in: PubMed
    99. Gomella LG. Celebrating the death of PSA screening? Can J Urol. 2011 Dec; 18(6):5987. PMID: 22166323.
      View in: PubMed
    100. Djavan B, Eastham J, Gomella L, Tombal B, Taneja S, Dianat SS, Kazzazi A, Shore N, Abrahamsson PA, Cheetham P, Moul J, Lepor H, Crawford ED. Testosterone in prostate cancer: the Bethesda consensus. BJU Int. 2012 Aug; 110(3):344-52. PMID: 22129242.
      View in: PubMed
    101. Moul JW, Evans CP, Gomella LG, Roach M, Dreicer R. Traditional approaches to androgen deprivation therapy. Urology. 2011 Nov; 78(5 Suppl):S485-93. PMID: 22054920.
      View in: PubMed
    102. Miller-Samuel S, Rosenberg A, Berger A, Gomella L, Loren D, Morris GJ. BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management. Semin Oncol. 2011 Oct; 38(5):605-11. PMID: 21943665.
      View in: PubMed
    103. Eldredge HB, Studenski M, Keith SW, Trabulsi E, Lallas CD, Gomella LG, Dicker AP, Showalter TN. Post-prostatectomy image-guided radiation therapy: evaluation of toxicity and inter-fraction variation using online cone-beam CT. J Med Imaging Radiat Oncol. 2011 Oct; 55(5):507-15. PMID: 22008172.
      View in: PubMed
    104. Gomella LG. How many clicks does it take to get to the middle of an EHR? Can J Urol. 2011 Oct; 18(5):5860. PMID: 22018145.
      View in: PubMed
    105. Gomella LG, Liu XS, Trabulsi EJ, Kelly WK, Myers R, Showalter T, Dicker A, Wender R. Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol. 2011 Oct; 18(5):5875-83. PMID: 22018148.
      View in: PubMed
    106. Gomella LG. Editor's note: Re: Screening for prostate cancer: the current evidence and guidelines controversy. Can J Urol. 2011 Oct; 18(5):5883. PMID: 22018149.
      View in: PubMed
    107. Trabulsi EJ, Zola JC, Colon-Herdman A, Heckman JE, Gomella LG, Lallas CD. Minimally invasive radical prostatectomy: transition from pure laparoscopic to robotic-assisted radical prostatectomy. Arch Esp Urol. 2011 Oct; 64(8):823-9. PMID: 22052763.
      View in: PubMed
    108. Gomella LG. The prostate cancer unit: a multidisciplinary approach for which the time has arrived. Eur Urol. 2011 Dec; 60(6):1197-9. PMID: 21871712.
      View in: PubMed
    109. Iozzo RV, Buraschi S, Genua M, Xu SQ, Solomides CC, Peiper SC, Gomella LG, Owens RC, Morrione A. Decorin antagonizes IGF receptor I (IGF-IR) function by interfering with IGF-IR activity and attenuating downstream signaling. J Biol Chem. 2011 Oct 7; 286(40):34712-21. PMID: 21840990.
      View in: PubMed
    110. Gomella LG, Gelpi F, Kelly WK. New treatment options for castrate-resistant prostate cancer: a urology perspective. Can J Urol. 2011 Aug; 18(4):5767-77. PMID: 21854708.
      View in: PubMed
    111. Gomella LG. Name that prostate cancer drug. Can J Urol. 2011 Jun; 18(3):5666. PMID: 21703036.
      View in: PubMed
    112. Ismail M, Ferroni M, Gomella LG. Androgen suppression strategies for prostate cancer: is there an ideal approach? Curr Urol Rep. 2011 Jun; 12(3):188-96. PMID: 21384154.
      View in: PubMed
    113. Showalter TN, Ohri N, Teti KG, Foley KA, Keith SW, Trabulsi EJ, Lallas CD, Dicker AP, Hoffman-Censits J, Pizzi LT, Gomella LG. Physician beliefs and practices for adjuvant and salvage radiation therapy after prostatectomy. Int J Radiat Oncol Biol Phys. 2012 Feb 1; 82(2):e233-8. PMID: 21605945.
      View in: PubMed
    114. Fassan M, D'Arca D, Letko J, Vecchione A, Gardiman MP, McCue P, Wildemore B, Rugge M, Shupp-Byrne D, Gomella LG, Morrione A, Iozzo RV, Baffa R. Mitostatin is down-regulated in human prostate cancer and suppresses the invasive phenotype of prostate cancer cells. PLoS One. 2011; 6(5):e19771. PMID: 21573075.
      View in: PubMed
    115. Lawton CA, Hunt D, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky TM, Sandler H. Long-term results of a phase II trial of ultrasound-guided radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (RTOG 98-05). Int J Radiat Oncol Biol Phys. 2011 Sep 1; 81(1):1-7. PMID: 21470793.
      View in: PubMed
    116. Liu XS, Folia C, Gomella LG. Pharmacology for common urologic diseases: 2011 review for the primary care physician. Can J Urol. 2011 Apr; 18 Suppl:24-38. PMID: 21501548.
      View in: PubMed
    117. Gomella LG. Editorial: do you trust your testosterone level? Can J Urol. 2011 Apr; 18(2):5581. PMID: 21504643.
      View in: PubMed
    118. Gomella LG. Teaching old prostate drugs new tricks in the battle against prostate cancer. Can J Urol. 2011 Feb; 18(1):5500. PMID: 21333039.
      View in: PubMed
    119. Sharma A, Yeow WS, Ertel A, Coleman I, Clegg N, Thangavel C, Morrissey C, Zhang X, Comstock CE, Witkiewicz AK, Gomella L, Knudsen ES, Nelson PS, Knudsen KE. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression. J Clin Invest. 2010 Dec; 120(12):4478-92. PMID: 21099110.
      View in: PubMed
    120. Andriole GL, Bostwick D, Brawley OW, Gomella L, Marberger M, Montorsi F, Pettaway C, Tammela TL, Teloken C, Tindall D, Freedland SJ, Somerville MC, Wilson TH, Fowler I, Castro R, Rittmaster RS. The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: results from the REDUCE study. J Urol. 2011 Jan; 185(1):126-31. PMID: 21074214.
      View in: PubMed
    121. Gomella LG, Lin J, Hoffman-Censits J, Dugan P, Guiles F, Lallas CD, Singh J, McCue P, Showalter T, Valicenti RK, Dicker A, Trabulsi EJ. Enhancing prostate cancer care through the multidisciplinary clinic approach: a 15-year experience. J Oncol Pract. 2010 Nov; 6(6):e5-e10. PMID: 21358951.
      View in: PubMed
    122. Gomella LG. Male enhancement products: kudos to the FDA. Can J Urol. 2010 Oct; 17(5):5343. PMID: 20974023.
      View in: PubMed
    123. Lallas CD, Pe ML, Thumar AB, Chandrasekar T, Lee FC, McCue P, Gomella LG, Trabulsi EJ. Comparison of lymph node yield in robot-assisted laparoscopic prostatectomy with that in open radical retropubic prostatectomy. BJU Int. 2011 Apr; 107(7):1136-40. PMID: 20825403.
      View in: PubMed
    124. Trabulsi EJ, Sackett D, Gomella LG, Halpern EJ. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology. 2010 Nov; 76(5):1025-33. PMID: 20719368.
      View in: PubMed
    125. Singh J, Trabulsi EJ, Gomella LG. Is there an optimal management for localized prostate cancer? Clin Interv Aging. 2010; 5:187-97. PMID: 20711438.
      View in: PubMed
    126. Gomella LG, Singh J, Lallas C, Trabulsi EJ. Hormone therapy in the management of prostate cancer: evidence-based approaches. Ther Adv Urol. 2010 Aug; 2(4):171-81. PMID: 21789093.
      View in: PubMed
    127. Trabulsi EJ, Patel J, Viscusi ER, Gomella LG, Lallas CD. Preemptive multimodal pain regimen reduces opioid analgesia for patients undergoing robotic-assisted laparoscopic radical prostatectomy. Urology. 2010 Nov; 76(5):1122-4. PMID: 20570321.
      View in: PubMed
    128. Gomella LG. Prostate cancer chemoprevention: more than meets the eye. Can J Urol. 2010 Jun; 17(3):5148. PMID: 20566004.
      View in: PubMed
    129. Singh J, Trabulsi EJ, Gomella LG. The quality-of-life impact of prostate cancer treatments. Curr Urol Rep. 2010 May; 11(3):139-46. PMID: 20425619.
      View in: PubMed
    130. Gomella LG. Re: Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer. Eur Urol. 2010 May; 57(5):915-6. PMID: 20945545.
      View in: PubMed
    131. Metalli D, Lovat F, Tripodi F, Genua M, Xu SQ, Spinelli M, Alberghina L, Vanoni M, Baffa R, Gomella LG, Iozzo RV, Morrione A. The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin. Am J Pathol. 2010 Jun; 176(6):2997-3006. PMID: 20395438.
      View in: PubMed
    132. Gomella LG. Prostate cancer screening "reloaded". Can J Urol. 2010 Apr; 17(2):5057. PMID: 20398441.
      View in: PubMed
    133. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, Pettaway CA, Tammela TL, Teloken C, Tindall DJ, Somerville MC, Wilson TH, Fowler IL, Rittmaster RS. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010 Apr 1; 362(13):1192-202. PMID: 20357281.
      View in: PubMed
    134. Gomella LG. Doctor google and the internet prescription. Can J Urol. 2010 Feb; 17(1):4971. PMID: 20156374.
      View in: PubMed
    135. Gomella LG, Lallas CD, Perkel R, Folia C, Hirsch I, Das A, Shenot P. Uropharmacology in primary care: 2010 update. Can J Urol. 2010 Feb; 17 Suppl 1:35-51. PMID: 20170599.
      View in: PubMed
    136. Trabulsi EJ, Zola JC, Gomella LG, Lallas CD. Transition from pure laparoscopic to robotic-assisted radical prostatectomy: a single surgeon institutional evolution. Urol Oncol. 2010 Jan-Feb; 28(1):81-5. PMID: 20123354.
      View in: PubMed
    137. Sartor O, Gomella LG, Gagnier P, Melich K, Dann R. Dutasteride and bicalutamide in patients with hormone-refractory prostate cancer: the Therapy Assessed by Rising PSA (TARP) study rationale and design. Can J Urol. 2009 Oct; 16(5):4806-12. PMID: 19796455.
      View in: PubMed
    138. Gomella LG. Health policy: Do end-of-life discussions have a role in health care reform? Nat Rev Urol. 2009 Oct; 6(10):524-5. PMID: 19806168.
      View in: PubMed
    139. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A. MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol. 2009 Oct; 219(2):214-21. PMID: 19593777.
      View in: PubMed
    140. Comstock CE, Augello MA, Benito RP, Karch J, Tran TH, Utama FE, Tindall EA, Wang Y, Burd CJ, Groh EM, Hoang HN, Giles GG, Severi G, Hayes VM, Henderson BE, Le Marchand L, Kolonel LN, Haiman CA, Baffa R, Gomella LG, Knudsen ES, Rui H, Henshall SM, Sutherland RL, Knudsen KE. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer. Clin Cancer Res. 2009 Sep 1; 15(17):5338-49. PMID: 19706803.
      View in: PubMed
    141. Gomella LG, Johannes J, Trabulsi EJ. Current prostate cancer treatments: effect on quality of life. Urology. 2009 May; 73(5 Suppl):S28-35. PMID: 19375624.
      View in: PubMed
    142. Pe ML, Trabulsi EJ, Kedika R, Pequignot E, Dicker AP, Gomella LG, Valicenti RK. Effect of percentage of positive prostate biopsy cores on biochemical outcome in low-risk PCa treated with brachytherapy or 3D-CRT. Urology. 2009 Jun; 73(6):1328-34. PMID: 19376564.
      View in: PubMed
    143. D'Arca D, LeNoir J, Wildemore B, Gottardo F, Bragantini E, Shupp-Byrne D, Zanesi N, Fassan M, Croce CM, Gomella LG, Baffa R. Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. Urol Oncol. 2010 Mar-Apr; 28(2):189-94. PMID: 19372053.
      View in: PubMed
    144. Lallas CD, Pe ML, Patel JV, Sharma P, Gomella LG, Trabulsi EJ. Transperitoneal robotic-assisted laparoscopic prostatectomy after prosthetic mesh herniorrhaphy. JSLS. 2009 Apr-Jun; 13(2):142-7. PMID: 19660206.
      View in: PubMed
    145. Gomella LG. Editorial comment on: A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol. 2009 Aug; 56(2):296-7. PMID: 19285789.
      View in: PubMed
    146. Lovat F, Bitto A, Xu SQ, Fassan M, Goldoni S, Metalli D, Wubah V, McCue P, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin is an autocrine growth factor for bladder cancer. Carcinogenesis. 2009 May; 30(5):861-8. PMID: 19237611.
      View in: PubMed
    147. Gomella LG. From the Lichtleiter to capsule cystoscopy. Eur Urol. 2009 May; 55(5):1034-6. PMID: 19246152.
      View in: PubMed
    148. Linden RA, Weiner PR, Gomella LG, Dicker AP, Suh DB, Trabulsi EJ, Valicenti RK. Technique of outpatient placement of intraprostatic fiducial markers before external beam radiotherapy. Urology. 2009 Apr; 73(4):881-6. PMID: 19193411.
      View in: PubMed
    149. Gomella LG. The impact of the impact factor. Can J Urol. 2009 Feb; 16(1):4445-6. PMID: 19222878.
      View in: PubMed
    150. Monami G, Emiliozzi V, Bitto A, Lovat F, Xu SQ, Goldoni S, Fassan M, Serrero G, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin regulates prostate cancer cell biology by promoting cell growth, migration, and anchorage-independent growth. Am J Pathol. 2009 Mar; 174(3):1037-47. PMID: 19179604.
      View in: PubMed
    151. Gomella LG. Effective testosterone suppression for prostate cancer: is there a best castration therapy? Rev Urol. 2009; 11(2):52-60. PMID: 19680526.
      View in: PubMed
    152. Gomella LG. Percutaneous nephrostolithotomy--is it time to abandon extracorporeal shock wave lithotripsy? J Urol. 2009 Jan; 181(1):11-2. PMID: 19012903.
      View in: PubMed
    153. Patel JV, Chambers CV, Gomella LG. Hematuria: etiology and evaluation for the primary care physician. Can J Urol. 2008 Aug; 15 Suppl 1:54-61; discussion 62. PMID: 18700066.
      View in: PubMed
    154. Gittens PR, Lallas CD, Pe ML, Perkel R, Folia C, Gomella LG. Uropharmacology for the primary care physician. Can J Urol. 2008 Aug; 15 Suppl 1:78-91; discussion 91. PMID: 18700069.
      View in: PubMed
    155. Trabulsi EJ, Linden RA, Gomella LG, McGinnis DE, Strup SE, Lallas CD. The addition of robotic surgery to an established laparoscopic radical prostatectomy program: effect on positive surgical margins. Can J Urol. 2008 Apr; 15(2):3994-9. PMID: 18405448.
      View in: PubMed
    156. Gomella LG. Re: identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. Eur Urol. 2008 Apr; 53(4):855-6. PMID: 18441534.
      View in: PubMed
    157. Brown JA, Chenven E, Looney SW, Miller KM, Strup SE, Bagley DH, Gomella LG. Hand-assisted laparoscopic nephroureterectomy (HALNU): an assessment of the impact of obesity in 50 procedures. J Laparoendosc Adv Surg Tech A. 2008 Feb; 18(1):61-8. PMID: 18266577.
      View in: PubMed
    158. Baffa R, Fassan M, Sevignani C, Vecchione A, Ishii H, Giarnieri E, Iozzo RV, Gomella LG, Croce CM. Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. Carcinogenesis. 2008 Apr; 29(4):846-8. PMID: 18192690.
      View in: PubMed
    159. Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology. 2007 Dec; 70(6):1136-40. PMID: 18158034.
      View in: PubMed
    160. Fassan M, Trabulsi EJ, Gomella LG, Baffa R. Targeted therapies in the management of metastatic bladder cancer. Biologics. 2007 Dec; 1(4):393-406. PMID: 19707309.
      View in: PubMed
    161. Linden RA, Trabulsi EJ, Forsberg F, Gittens PR, Gomella LG, Halpern EJ. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol. 2007 Dec; 178(6):2354-8. PMID: 17936814.
      View in: PubMed
    162. Glassman DT, Merriam WG, Trabulsi EJ, Byrne D, Gomella L. Rhabdomyolysis after laparoscopic nephrectomy. JSLS. 2007 Oct-Dec; 11(4):432-7. PMID: 18237506.
      View in: PubMed
    163. Chodak G, Gomella L, Phung de H. Combined androgen blockade in advanced prostate cancer: looking back to move forward. Clin Genitourin Cancer. 2007 Sep; 5(6):371-8. PMID: 17956709.
      View in: PubMed
    164. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, Gomella LG, Croce CM, Baffa R. Micro-RNA profiling in kidney and bladder cancers. Urol Oncol. 2007 Sep-Oct; 25(5):387-92. PMID: 17826655.
      View in: PubMed
    165. Glassman D, Chawla SN, Waldman I, Johannes J, Byrne DS, Trabulsi EJ, Gomella LG. Correlation of pathology with tumor size of renal masses. Can J Urol. 2007 Aug; 14(4):3616-20. PMID: 17784981.
      View in: PubMed
    166. Duchene DA, Winfield HN, Cadeddu JA, Clayman RV, Gomella LG, Kavoussi LR, Mikhail AA, Park S, Permpongkosol S, Shalhav AL. Multi-institutional survey of laparoscopic ureterolysis for retroperitoneal fibrosis. Urology. 2007 Jun; 69(6):1017-21. PMID: 17572177.
      View in: PubMed
    167. Fleshner N, Gomella LG, Cookson MS, Finelli A, Evans A, Taneja SS, Lucia MS, Wolford E, Somerville MC, Rittmaster R. Delay in the progression of low-risk prostate cancer: rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial. Contemp Clin Trials. 2007 Nov; 28(6):763-9. PMID: 17573244.
      View in: PubMed
    168. Grossman HB, Gomella L, Fradet Y, Morales A, Presti J, Ritenour C, Nseyo U, Droller MJ. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer. J Urol. 2007 Jul; 178(1):62-7. PMID: 17499283.
      View in: PubMed
    169. Fradet Y, Grossman HB, Gomella L, Lerner S, Cookson M, Albala D, Droller MJ. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study. J Urol. 2007 Jul; 178(1):68-73; discussion 73. PMID: 17499291.
      View in: PubMed
    170. Abraham R, Pagano F, Gomella LG, Baffa R. Chromosomal deletions in bladder cancer: shutting down pathways. Front Biosci. 2007; 12:826-38. PMID: 17127340.
      View in: PubMed
    171. Gomella LG. Global update on the use of hormonal therapy for the management of high-risk prostate cancer: introduction. BJU Int. 2007 Jan; 99 Suppl 1:1. PMID: 17229158.
      View in: PubMed
    172. Gomella LG. Contemporary use of hormonal therapy in prostate cancer: managing complications and addressing quality-of-life issues. BJU Int. 2007 Jan; 99 Suppl 1:25-9; discussion 30. PMID: 17229166.
      View in: PubMed
    173. Lawton CA, DeSilvio M, Lee WR, Gomella L, Grignon D, Gillin M, Morton G, Pisansky T, Sandler H. Results of a phase II trial of transrectal ultrasound-guided permanent radioactive implantation of the prostate for definitive management of localized adenocarcinoma of the prostate (radiation therapy oncology group 98-05). Int J Radiat Oncol Biol Phys. 2007 Jan 1; 67(1):39-47. PMID: 17084551.
      View in: PubMed
    174. Monami G, Gonzalez EM, Hellman M, Gomella LG, Baffa R, Iozzo RV, Morrione A. Proepithelin promotes migration and invasion of 5637 bladder cancer cells through the activation of ERK1/2 and the formation of a paxillin/FAK/ERK complex. Cancer Res. 2006 Jul 15; 66(14):7103-10. PMID: 16849556.
      View in: PubMed
    175. Brown JA, Garlitz CJ, Hubosky SG, Gomella LG. Hand-assisted laparoscopic ureterolysis to treat ureteral obstruction secondary to idiopathic retroperitoneal fibrosis: assessment of a novel technique and initial series. Urology. 2006 Jul; 68(1):46-9. PMID: 16806417.
      View in: PubMed
    176. Gomella LG. Targeting the genetic basis of transitional cell carcinoma. J Urol. 2006 Jun; 175(6):1986. PMID: 16697780.
      View in: PubMed
    177. Trabulsi EJ, Merriam WG, Gomella LG. New imaging techniques in prostate cancer. Curr Urol Rep. 2006 May; 7(3):175-80. PMID: 16630520.
      View in: PubMed
    178. Kalra P, Glassman DT, Gomella LG, Strup SE, McGinnis DE, Simon DR, Chang MF, Byrne DS, Kuo RL. Outcomes of hand-assisted laparoscopic nephrectomy in technically challenging cases. Urology. 2006 Jan; 67(1):45-9. PMID: 16413330.
      View in: PubMed
    179. Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer. 2005 Dec 1; 104(11):2373-83. PMID: 16240450.
      View in: PubMed
    180. Brown JA, Strup SE, Chenven E, Bagley D, Gomella LG. Hand-assisted laparoscopic nephroureterectomy: analysis of distal ureterectomy technique, margin status, and surgical outcomes. Urology. 2005 Dec; 66(6):1192-6. PMID: 16360439.
      View in: PubMed
    181. Ives EP, Gomella LG, Halpern EJ. Effect of dutasteride therapy on Doppler US evaluation of prostate: preliminary results. Radiology. 2005 Oct; 237(1):197-201. PMID: 16183933.
      View in: PubMed
    182. Ives EP, Burke MA, Edmonds PR, Gomella LG, Halpern EJ. Quantitative computed tomography perfusion of prostate cancer: correlation with whole-mount pathology. Clin Prostate Cancer. 2005 Sep; 4(2):109-12. PMID: 16197611.
      View in: PubMed
    183. Strup S, Garrett J, Gomella L, Rowland R. Laparoscopic partial nephrectomy: hand-assisted technique. J Endourol. 2005 May; 19(4):456-9; discussion 459-60. PMID: 15910255.
      View in: PubMed
    184. Moreno JG, Miller MC, Gross S, Allard WJ, Gomella LG, Terstappen LW. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology. 2005 Apr; 65(4):713-8. PMID: 15833514.
      View in: PubMed
    185. Trabulsi EJ, Kalra P, Gomella LG. New approaches to the minimally invasive treatment of kidney tumors. Cancer J. 2005 Jan-Feb; 11(1):57-63. PMID: 15831225.
      View in: PubMed
    186. Gomella LG. Chemoprevention using dutasteride: the REDUCE trial. Curr Opin Urol. 2005 Jan; 15(1):29-32. PMID: 15586026.
      View in: PubMed
    187. Gomella LG. Addressing the needs of the high-risk prostate cancer patient. Rev Urol. 2005; 7 Suppl 5:S18-28. PMID: 16985880.
      View in: PubMed
    188. Brown JA, Garlitz C, Strup SE, Hubosky SG, Gomella L. Laparoscopic radical prostatectomy after neoadjuvant hormonal therapy: an apparently safe and effective procedure. J Laparoendosc Adv Surg Tech A. 2004 Dec; 14(6):335-8. PMID: 15684777.
      View in: PubMed
    189. Vecchione A, Sevignani C, Giarnieri E, Zanesi N, Ishii H, Cesari R, Fong LY, Gomella LG, Croce CM, Baffa R. Inactivation of the FHIT gene favors bladder cancer development. Clin Cancer Res. 2004 Nov 15; 10(22):7607-12. PMID: 15569992.
      View in: PubMed
    190. Andriole G, Bostwick D, Brawley O, Gomella L, Marberger M, Tindall D, Breed S, Somerville M, Rittmaster R. Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. J Urol. 2004 Oct; 172(4 Pt 1):1314-7. PMID: 15371831.
      View in: PubMed
    191. Vecchione A, Galetti TP, Gardiman M, Ishii H, Giarnieri E, Pagano F, Gomella LG, Croce CM, Baffa R. Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases. BMC Urol. 2004 Sep 9; 4:11. PMID: 15357873.
      View in: PubMed
    192. Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology. 2004 Jul; 64(1):84-9. PMID: 15245941.
      View in: PubMed
    193. Gomella LG. When prostate cancer markers become unreliable: the PCPT dilemma. Urol Oncol. 2004 May-Jun; 22(3):260-1. PMID: 15495370.
      View in: PubMed
    194. Brown JA, Hubosky SG, Gomella LG, Strup SE. Hand assisted laparoscopic partial nephrectomy for peripheral and central lesions: a review of 30 consecutive cases. J Urol. 2004 Apr; 171(4):1443-6. PMID: 15017194.
      View in: PubMed
    195. Valicenti RK, Chervoneva I, Gomella LG. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15; 58(4):1093-7. PMID: 15001249.
      View in: PubMed
    196. Brown JA, Garlitz C, Gomella LG, McGinnis DE, Diamond SM, Strup SE. Perioperative morbidity of laparoscopic radical prostatectomy compared with open radical retropubic prostatectomy. Urol Oncol. 2004 Mar-Apr; 22(2):102-6. PMID: 15082005.
      View in: PubMed
    197. O'Hara SM, Moreno JG, Zweitzig DR, Gross S, Gomella LG, Terstappen LW. Multigene reverse transcription-PCR profiling of circulating tumor cells in hormone-refractory prostate cancer. Clin Chem. 2004 May; 50(5):826-35. PMID: 14988224.
      View in: PubMed
    198. Gomella LG, Zeltser I, Valicenti RK. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer. Urology. 2003 Dec 29; 62 Suppl 1:46-54. PMID: 14747041.
      View in: PubMed
    199. Brown JA, Garlitz C, Gomella LG, Hubosky SG, Diamond SM, McGinnis D, Strup SE. Pathologic comparison of laparoscopic versus open radical retropubic prostatectomy specimens. Urology. 2003 Sep; 62(3):481-6. PMID: 12946751.
      View in: PubMed
    200. Gomella LG. Laparoscopy and urologic oncology--I now pronounce you man and wife. J Urol. 2003 Jun; 169(6):2057-8. PMID: 12771718.
      View in: PubMed
    201. Valicenti RK, Gomella LG, Perez CA. Radiation therapy after radical prostatectomy: a review of the issues and options. Semin Radiat Oncol. 2003 Apr; 13(2):130-40. PMID: 12728442.
      View in: PubMed
    202. Halpern EJ, Gomella LG. Pseudomass of the bladder neck after prostatectomy: report of two cases. Radiology. 2003 Mar; 226(3):833-5. PMID: 12601184.
      View in: PubMed
    203. Wilkinson S, Gomella LG, Smith JA, Brawer MK, Dawson NA, Wajsman Z, Dai L, Chodak GW. Attitudes and use of complementary medicine in men with prostate cancer. J Urol. 2002 Dec; 168(6):2505-9. PMID: 12441950.
      View in: PubMed
    204. Halpern EJ, Frauscher F, Strup SE, Nazarian LN, O'Kane P, Gomella LG. Prostate: high-frequency Doppler US imaging for cancer detection. Radiology. 2002 Oct; 225(1):71-7. PMID: 12354987.
      View in: PubMed
    205. Halpern EJ, Frauscher F, Rosenberg M, Gomella LG. Directed biopsy during contrast-enhanced sonography of the prostate. AJR Am J Roentgenol. 2002 Apr; 178(4):915-9. PMID: 11906872.
      View in: PubMed
    206. Vecchione A, Ishii H, Baldassarre G, Bassi P, Trapasso F, Alder H, Pagano F, Gomella LG, Croce CM, Baffa R. FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells. Am J Pathol. 2002 Apr; 160(4):1345-52. PMID: 11943719.
      View in: PubMed
    207. Halpern EJ, Frauscher F, Forsberg F, Strup SE, Nazarian LN, O'Kane P, Gomella LG. High-frequency Doppler US of the prostate: effect of patient position. Radiology. 2002 Mar; 222(3):634-9. PMID: 11867778.
      View in: PubMed
    208. Lee D, Trabulsi E, McGinnis D, Strup S, Gomella LG, Bagley D. Totally endoscopic management of upper tract transitional-cell carcinoma. J Endourol. 2002 Feb; 16(1):37-41. PMID: 11890449.
      View in: PubMed
    209. Halpern EJ, McCue PA, Aksnes AK, Hagen EK, Frauscher F, Gomella LG. Contrast-enhanced US of the prostate with Sonazoid: comparison with whole-mount prostatectomy specimens in 12 patients. Radiology. 2002 Feb; 222(2):361-6. PMID: 11818600.
      View in: PubMed
    210. Sandler H, Shipley WU, Gomella L, Pienta K, Bard RH, Bruner D, Clark R, DeSilvio M, Gaspar L, Gillin M, Grignon D, Hammond E, Hanks G, Heydon KH, Kaufman DS, Lee WR, Michalski J, Mydlo J, Pisansky T, Pollack A, Porterfield H, Rifkin M, Roach M, Sanda M, True L, Vijayakumar S, Winter KA, Zeitman A. Radiation Therapy Oncology Group. Research Plan 2002-2006. Genitourinary Cancer Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):28-38. PMID: 11641012.
      View in: PubMed
    211. Ginsburg R, Bullard D, Eisenberg B, Gomella L, Johnstone D, Pisters PW, Sigurdson E, Weber R, Levenback C. Radiation Therapy Oncology Group. Research Plan 2002-2006. Surgical Oncology Committee. Int J Radiat Oncol Biol Phys. 2001; 51(3 Suppl 2):92-5. PMID: 11641022.
      View in: PubMed
    212. Mastrangelo MJ, Eisenlohr LC, Gomella L, Lattime EC. Poxvirus vectors: orphaned and underappreciated. J Clin Invest. 2000 Apr; 105(8):1031-4. PMID: 10772644.
      View in: PubMed
    213. Corn BW, Valicenti RK, Mulholland SG, Hyslop T, Gomella L. Stage T3 prostate cancer: a nonrandomized comparison between definitive irradiation and induction hormonal manipulation plus prostatectomy. Urology. 1998 May; 51(5):782-7. PMID: 9610592.
      View in: PubMed
    214. Hudes GR, Nathan F, Khater C, Haas N, Cornfield M, Giantonio B, Greenberg R, Gomella L, Litwin S, Ross E, Roethke S, McAleer C. Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. J Clin Oncol. 1997 Sep; 15(9):3156-63. PMID: 9294479.
      View in: PubMed
    215. Werner-Wasik M, Whittington R, Malkowicz SB, Corn BW, Arger P, Reisinger S, Langlotz C, Alexander A, D'Amico AV, Hyslop T, Gomella L, Brownstein K, Wein AJ. Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate. Urology. 1997 Sep; 50(3):385-9. PMID: 9301702.
      View in: PubMed
    216. Rosen EM, Joseph A, Jin L, Yao Y, Chau MH, Fuchs A, Gomella L, Hastings H, Goldberg ID, Weiss GH. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. J Urol. 1997 Jan; 157(1):72-8. PMID: 8976219.
      View in: PubMed
    217. Watanabe T, Rivas DA, Miettinen M, Gomella L, Chancellor MB. Total incontinence secondary to sphincter destruction after prostate cryotherapy for recurrent prostatic carcinoma. Int J Urol. 1996 Jul; 3(4):324-5. PMID: 8844295.
      View in: PubMed
    218. Hudes GR, Nathan FE, Khater C, Greenberg R, Gomella L, Stern C, McAleer C. Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer. Semin Oncol. 1995 Oct; 22(5 Suppl 12):41-5. PMID: 7481860.
      View in: PubMed
    219. Bishoff JT, Reyes A, Thompson IM, Harris MJ, St Clair SR, Gomella L, Butzin CA. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology. 1995 Feb; 45(2):270-4. PMID: 7531901.
      View in: PubMed
    220. Spencer JA, Alexander AA, Gomella L, Matteucci T, Goldberg BB. Ultrasound-guided four quadrant biopsy of the prostate: efficacy in the diagnosis of isoechoic cancer. Clin Radiol. 1994 Oct; 49(10):711-4. PMID: 7955836.
      View in: PubMed
    221. Spencer JA, Alexander AA, Gomella L, Matteucci T, Goldberg BB. Clinical and US findings in prostate cancer: patients with normal prostate-specific antigen levels. Radiology. 1993 Nov; 189(2):389-93. PMID: 7692464.
      View in: PubMed
    222. Pietrzkowski Z, Mulholland G, Gomella L, Jameson BA, Wernicke D, Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res. 1993 Mar 1; 53(5):1102-6. PMID: 8439954.
      View in: PubMed
    223. Haas GP, Pittaluga S, Gomella L, Travis WD, Sherins RJ, Doppman JL, Linehan WM, Robertson C. Clinically occult Leydig cell tumor presenting with gynecomastia. J Urol. 1989 Nov; 142(5):1325-7. PMID: 2810523.
      View in: PubMed
    Gomella's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _